Reduxin Forte
| LP-005315 | |
| Name | Reduxin Forte |
| Dosage form | Tablets |
| INN | Metformin + Sibutramine |
| Active agent | Active substances: metformin hydrochloride – 850.0 mg; sibutramine hydrochloride monohydrate – 15.0 mg; Excipients: microcrystalline cellulose, croscarmellose sodium, povidone K-25, magnesium stearate; Film coating excipients: Complete film coating system Opadry II 85F48105 white (polyvinyl alcohol, macrogol, talc, titanium dioxide). |
Reduxin Forte is second to none in the weight loss market.
The drug won the international award "Innovative Product" 20211. Its patented formula with the complementary action of components recognized as standards in the field of appetite and metabolism control allows one to comprehensively solve the problem of excess weight. Unlike other weight-loss agents, from the first day of treatment Reduxin Forte:
reduces hunger and forms proper eating behavior;
normalizes carbohydrate and lipid metabolism;
increases internal energy consumption.
The combined action of Reduxin Forte not only reduces body weight, but also restores metabolic health, which contributes to the prevention of complications and allows you to enjoy life for many years and enjoy it as much as possible:
significantly reduces weight and waist circumference in 90% of people after 3 months;
accelerates the breakdown of fats and carbohydrates, reduces the level of atherogenic blood fractions;
reduces the risk of developing diabetes mellitus and cancer, increases the chances of conception and birth of a healthy child, protects the heart and vessels from atherosclerosis, prolongs active healthy life.
Reduxin Forte is indicated for:
Correction of body weight and improving lipid and carbohydrate metabolism in overweight patients *.
How to use**:
Reduxin Forte is convenient and easy to use: only 1 tablet per day continuously up to 1 year.
Dry mouth and feeling of thirst during treatment means that the active process of breakdown of adipose tissue and weight loss has begun; adequate drinking regime is recommended.
Notes:
Do not use in children and pregnant women.
Sources:
* According to the prescribing information, body weight correction and improvement of lipid and carbohydrate metabolism in patients with a BMI of 27 kg/m2 or more, with concomitant type 2 diabetes mellitus and dyslipidemia.
** Prescription product. Consult a doctor before use.
1. pharmvestnik.ru.
2. Prescribing information.
3. G. A. Matveev et al. Comparison of the effects of liraglutide and sibutramine in obesity therapy // Obesity and metabolism. — 2021. — Vol. 18. — No. 2. — pp. 218–228;
4. A.S. Ametov et al. Modern metabolic health management options in patients with obesity and carbohydrate metabolism disorders // Endocrinology: news, opinions, training. — 2020. — Vol. 9. — No. 1. — pp. 17–26. doi: 10.33029/2304-9529-2020-9-1-17-26.
